On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like <b>Harmony Biosciences</b> Gains U.S. Rights to Pitolisant, Raises $270 Million October 5, 2017 FDA Grants Evofem Biosciences’ Amphora Fast Track Designation February 20, 2018 LivaNova PLC CFO Resigns March 30, 2017
